Hepatitis vaccines.
The 1980s represented a decade of breakthroughs for the development of hepatitis vaccines. Plasma-derived and then recombinant hepatitis B vaccines were developed and introduced, killed hepatitis A vaccine was developed, and the virologic tools were discovered with which to lay the groundwork for a vaccine against hepatitis C. Even as the focus of the 1990s shifts toward antiviral therapy of chronic viral hepatitis, we cannot afford to neglect the importance of prevention by vaccination. Better vaccines and improved vaccination strategies for preventing hepatitis A and B will continue to demand research investment, and the most meager toehold will have to be exploited and pursued aggressively if a practical, effective hepatitis C vaccine is to be developed.
Katkov
W N
WN
University of California, Los Angeles, USA.
Dienstag
J L
JL
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006506:Hepatitis A / Q000517:prevention & control; D022362:Hepatitis A Vaccines; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines; D006526:Hepatitis C / Q000517:prevention & control; D006801:Humans; D007223:Infant; D014761:Viral Hepatitis Vaccines
D022362:Hepatitis A Vaccines; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines